SAMDaily.us | AWARD | 99 | Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula

SAMDAILY.US - ISSUE OF SEPTEMBER 27, 2026 SAM #9071
AWARD

99 -- Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula

Notice Date: 9/25/2026 2:52:45 PM
Notice Type: Award Notice
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Solicitation Number: BAA-23-100-SOL-00004
Archive Date: 10/10/2026
Point of Contact: Audrey Glover, Veronica Stroud
E-Mail Address: audrey.glover@hhs.gov, veronica.stroud@hhs.gov
(audrey.glover@hhs.gov, veronica.stroud@hhs.gov)
Award Number: 75A50126C00007
Award Date: 09/25/2026
Awardee: Scynexis, Inc. Jersey City NJ 07302 USA
Award Amount: 213943726.00
Web Link: SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/5d2b1c5f6d094d72ad9916f20fc33ed3/view)
Place of Performance: Address: Jersey City, NJ 07302, USA; Zip Code: 07302; Country: USA
Record: SN07986973-F 20260927/260925230037 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |